Cytopag 25 F/C Tablet Tablet

About Cytopag 25 F/C Tablet

The tablet Cytopag 25 F/C Tablet contains Eltrombopag and is made by Advanced Chemical Industries PLC. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

There are 7 brands of Eltrombopag listed in Bangladesh.

What is Cytopag 25 F/C Tablet?

Cytopag 25 F/C Tablet 25 mg tablet is a medicine made by Advanced Chemical Industries PLC. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy. Whether it suits you is a decision for your doctor.

Uses of Cytopag 25 F/C Tablet

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Ask your doctor whether it is right for your condition.

How to use Cytopag 25 F/C Tablet

Cytopag 25 F/C Tablet is taken by mouth. Swallow the tablet with water. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.

Side effects of Cytopag 25 F/C Tablet

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Tell your doctor about all the other medicines you take.

Frequently asked questions

Why is Cytopag 25 F/C Tablet prescribed?

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.

How is Cytopag 25 F/C Tablet used?

Cytopag 25 F/C Tablet is taken by mouth. Swallow the tablet with water.

What should I watch for while using Cytopag 25 F/C Tablet?

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Contact your doctor if you notice anything unusual after taking it.

Who should be careful with Cytopag 25 F/C Tablet?

Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown.

Alternative brands of Eltrombopag

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.